The biological vaccine sector weakened, and Watson biology fell more than 6%
The biological vaccine sector weakened. As of press time, Watson biology fell by more than 6%, Zhifei biology and Boya biology fell by more than 5%, Changchun hi tech fell by more than 4%, and Wantai biology, kangxinuo and dongfulong followed suit.
This text is a result of machine translation.
Related companies：
Briefing Updated 3 hours ago
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Briefing Oct 16, 2021 10:55 PM
Xingzheng strategy: the shareholding concentration of northward capital science and Innovation Board continues to be high
In depth
Briefing Oct 15, 2021 06:25 PM
· Healthcare
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Briefing Oct 13, 2021 05:53 PM
· Healthcare
Nanjing issued the city's energy conservation proposal: scientifically arrange production processes and production shifts, and actively stagger peak and avoid peak power consumption
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Apr 22, 2021 03:11 PM
Jan 28, 2021 01:11 PM
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Briefing Aug 16, 2021 10:26 AM
· Healthcare
Changchun hi tech: it will actively promote the corresponding sales of adult growth hormone deficiency indications
Financials
Futu Founder Leaf Hua Li Apologizes for System Failure
"We are sincerely sorry, and we humbly accept all criticism and advice. We will make relevant improvements immediately." Futu founder Leaf Hua Li publicly expresses remorse for the interruption of the morning of October 9, 2021.
Oct 12, 2021 02:27 PM
Briefing Aug 13, 2021 10:29 PM
· Healthcare
Changchun hi tech: the subsidiary intends to introduce the patent technology of an interleukin-2 mutant of Shanghai gaipu biology, and has the right to license it
Insight
Briefing Aug 05, 2021 02:53 PM
· Healthcare
Changchun hi tech: it has been adhering to standardized operation for many years, and will adhere to compliance operation as the bottom line in the future
Briefing Aug 05, 2021 02:20 PM
· Healthcare
Changchun hi tech: growth hormone is a prescription drug, which is sold to medical institutions that meet the requirements of laws and regulations
Briefing Aug 05, 2021 02:09 PM
· Healthcare
Changchun hi tech: in terms of adult indications of growth hormone, the company believes that the product has great market potential in the future
Briefing Aug 05, 2021 09:33 AM
· Healthcare
Changchun hi tech approaching the limit
See more
Read next
In depth
In depth
Insight
Consumer Staples, Consumer Discretionary
Medium Power: Reshaped China Consumption
Oct 14, 2021 11:09 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.